BLUE
JD
John De Vos
@jdevos.bsky.social
#stemcells researcher | Director of Cell Processing Facility University of Montpellier CHU of Montpellier | #StemCells #iPScells #lung | Stem Genomics co-founder | President of the FSSCR
17 followers19 following29 posts
JDjdevos.bsky.social

Fate Therapeutics started an #iPSCells-derived#CARTCellsclinicaltrials.gov/study/NCT063...

0
JDjdevos.bsky.social

ISSCR 2025 Annual Meeting Will Take Place In Hong Kong The world’s leading stem cell scientists will gather in Hong Kong, 11-14 June 2025, for the ISSCR 2025 Annual Meeting, co-sponsored by The University of Hong Kong. www.isscr.org/upcoming-pro...

ISSCR 2025 — International Society for Stem Cell Research
ISSCR 2025 — International Society for Stem Cell Research

Join us in Hong Kong 11-14 June 2025 for the most comprehensive gathering in stem cell research.

0
JDjdevos.bsky.social

World's first successful transplant of a xenothymokidney (a pig kidney and simultaneous pig thymus fragments) into a living recipient, using organs from a genetically modified pig from United Therapeutics Corporation. #Xenotransplantationir.unither.com/press-releas...

United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
United Therapeutics Announces World’s First Successful Xenothymokidney Transplant

The actual press release articles

0
JDjdevos.bsky.social

Lots of news on gene and cell therapy in the NEJM this week!😍 Exagamglogene Autotemcel (#CRISPR) for Transfusion-Dependent β-Thalassemia: transfusion independence in 91% of patients. | New England Journal of Medicine www.nejm.org/doi/full/10....

Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia | NEJM
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia | NEJM

Exagamglogene autotemcel (exa-cel) is a nonviral cell therapy designed to reactivate fetal hemoglobin synthesis through ex vivo clustered regularly interspaced short palindromic repeats (CRISPR)–Ca...

0
JDjdevos.bsky.social

Another phase I clinical trial demonstrating the safety and efficay of #CARTCellswww.nature.com/articles/s43...

0
JDjdevos.bsky.social

Positive results from a phase I study using @Gilead's anti-MAGE3 and MAGE6 #CARTCellswww.pharmaceutical-technology.com/data-insight...

0
JDjdevos.bsky.social

Stuart Orkin is part of the 100 most influential people of 2024 in TIME magazine for his discovery that one can treat several genetic hemoglobin diseases by turning on fetal hemoglobin normally silenced in adults. This lead to several FDA approved drugs. time.com/6964969/stua...

0
JD
John De Vos
@jdevos.bsky.social
#stemcells researcher | Director of Cell Processing Facility University of Montpellier CHU of Montpellier | #StemCells #iPScells #lung | Stem Genomics co-founder | President of the FSSCR
17 followers19 following29 posts